Document Preview Unavailable
KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC
Cinausero Marika; Laprovitera Noemi; Maglio, Giovanna De; Gerratana Lorenzo; Riefolo Mattia; et al. Therapeutic Advances in Medical Oncology Vol. 11, (Jan 2019).You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library